Phase I/II trial to establish safety, tolerability and efficacy of losartan in children with epidermolysis bullosa Phase I/II trial to establish safety, tolerability and efficacy of losartanin children with epidermo ...
A dual-center prospective phase I/II trial to establish safety, tolerability and to obtain first data on efficacy of losartan in children with recessive dystrophic epidermolysis bullosa (RDEB) - REFLECT A dual-center prospective phase I/II trial to establish safety, tolerability and to obtain first dat ...
Phase I/II trial to establish safety, tolerability and efficacy of losartan in children with epidermolysis bullosa Phase I/II trial to establish safety, tolerability and efficacy of losartanin children with epidermo ...
A dual-center prospective phase I/II trial to establish safety, tolerability and to obtain first data on efficacy of losartan in children with recessive dystrophic epidermolysis bullosa (RDEB) - REFLECT A dual-center prospective phase I/II trial to establish safety, tolerability and to obtain first dat ...